• Multi-Country Validation of SAMBA - A Novel Molecular Point-of- Care Test for HIV-1 Detection in Resource-Limited Setting

      Ondiek, J; Namukaya, Z; Mtapuri-Zinyowera, S; Balkan, S; Elbireer, A; Ushiro Lumb, I; Kiyaga, C; Goel, N; Ritchie, A; Ncube, P; Omuomu, K; Ndiege, K; Kekitiinwa, A; Mangwanya, D; Fowler, Mary G; Nadala, L; Lee, H (Lippincott Williams & Wilkins, 2017-06-09)
      Early diagnosis of HIV-1 infection and the prompt initiation of antiretroviral therapy are critical to achieving a reduction in the morbidity and mortality of infected infants. The SAMBA HIV-1 Qual Whole Blood Test was developed specifically for early infant diagnosis and prevention of mother-to-child transmission programs implemented at the point-of-care in resource-limited settings.